Literature DB >> 23464605

Clinical, imaging, and pathologic characteristics of Gurltia paralysans myelopathy in domestic cats from Chile.

Marcelo Mieres1, Marcelo A Gómez, Carla Lillo, Marcela A Rojas, Manuel Moroni, Pamela Muñoz, Gerardo Acosta-Jamett, Ricardo Wiegand.   

Abstract

Gurltia paralysans is a rare metastrongylid nematode of domestic cats that is found mainly in the veins of the spinal cord subarachnoid space and parenchyma. Endemic regions for G. paralysans mainly include Chile and Argentina. The ante mortem diagnosis of gurltiosis is difficult and based primarily on neurological signs, epidemiological factors, and the exclusion of other causes of feline myelopathies. The purpose of this retrospective case series was to describe clinical, imaging, and pathologic characteristics in nine domestic cats naturally infected with G. paralysans. Imaging tests included radiography, myelography, computed tomographic myelography (myelo-CT), and magnetic resonance imaging (MRI). Neurological signs included paraparesis, paraplegia, pelvic limb ataxia and proprioceptive deficits, pelvic limb tremors, lumbosacral hyperesthesia, and tail trembling or atony. Complete blood count findings included a decrease in the mean corpuscular hemoglobin concentration value in eight cats. Eosinophilia in peripheral blood was observed in three cats, and thrombocytopenia was observed in three cats. Cerebrospinal fluid analysis revealed mononuclear pleocytosis in five cases. Myelo-CT showed diffuse enlargement of the spinal cord at the midthoracic, lumbar, and sacral regions in all cats. Magnetic resonance image findings in the thoracic and lumbar region demonstrated multiple small nodular areas of T2 hyperintensity in the periphery of the spinal cord parenchyma. Localized intraparenchymal areas of increased T2 intensity were also observed in the thoracolumbar spinal cord and lumbosacral conus medullaris. In conclusion, G. paralysans should be considered as a differential diagnosis for domestic cats in endemic regions that have this combination of clinical and imaging characteristics.
© 2013 Veterinary Radiology & Ultrasound.

Entities:  

Mesh:

Year:  2013        PMID: 23464605     DOI: 10.1111/vru.12026

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  5 in total

Review 1.  Gurltia paralysans: A Neglected Angio-Neurotropic Parasite of Domestic Cats (Felis catus) and Free-Ranging Wild Felids (Leopardus spp.) in South America.

Authors:  Lisbeth Rojas-Barón; Anja Taubert; Carlos Hermosilla; Marcelo Gómez; Manuel Moroni; Pamela Muñoz
Journal:  Pathogens       Date:  2022-07-13

2.  First ocular report of Gurltia paralysans (Wolffhügel, 1933) in cat.

Authors:  Raquel Udiz-Rodríguez; Katherine Garcia-Livia; Maria Valladares-Salmerón; Maria Naira Dorta-Almenar; Natalia Martín-Carrillo; Aaron Martin-Alonso; Elena Izquierdo-Rodriguez; Carlos Feliu; Basilio Valladares; Pilar Foronda
Journal:  Vet Parasitol       Date:  2018-03-31       Impact factor: 2.738

3.  Intra Vitam Diagnosis of Neglected Gurltia paralysans Infections in Domestic Cats (Felis catus) by a Commercial Serology Test for Canine Angiostrongylosis and Insights into Clinical and Histopathological Findings-Four-Case Report.

Authors:  Marcelo Gómez; Catalina García; Isabel Maldonado; Nikola Pantchev; Anja Taubert; Carlos Hermosilla; Manuel Moroni; Pamela Muñoz; Alejandra Duran; Marcelo Mieres; Javier Ojeda
Journal:  Pathogens       Date:  2020-11-06

4.  Histological and Immunohistochemical Characterization of Vascular Alterations in Meninges of Cats Infected with Gurltia paralysans.

Authors:  Svenja Hartung; Angelika Weyrich; Manuel Moroni; Marcelo Gómez; Christiane Herden
Journal:  Pathogens       Date:  2022-01-12

Review 5.  The Neglected Angio-Neurotrophic Parasite Gurltia paralysans (Nematoda: Angiostrongylidae): Northernmost South American Distribution, Current Knowledge, and Future Perspectives.

Authors:  Manuel Uribe; Sara López-Osorio; Jenny J Chaparro-Gutiérrez
Journal:  Pathogens       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.